Epigenomics AG Share Price
Stocks
ECX
DE000A37FT41
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Deutsche Boerse AG
07:00:31 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.9100 EUR | +4.60% |
|
-4.21% | +1.11% |
| 09-03 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 763K 859K 714K 650K 1.22M 82.71M 1.24M 8.63M 3.34M 42.12M 3.23M 3.16M 135M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.73M 13.21M 10.97M 10M 18.82M 1.27B 19.08M 133M 51.37M 648M 49.58M 48.51M 2.08B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
Deutsche Boerse AGEUR
| Markets | Quality | ||
|---|---|---|---|
Deutsche Boerse AG
| ECX | Delayed | |
Börse Stuttgart
| ECX | Delayed | |
|
Boerse Muenchen
| ECX | Real-time |
| 1 day | +4.60% | ||
| 1 week | -4.21% | ||
| Current month | -4.21% | ||
| 1 month | +1.11% | ||
| 3 months | +4.60% | ||
| 6 months | +4.60% | ||
| Current year | +1.11% |
| 1 week | 0.87 |  | 0.96 |
| 1 month | 0.87 | | 1.01 |
| Current year | 0.84 | | 1.56 |
| 1 year | 0.84 | | 1.59 |
| 3 years | 0.5 | | 3.25 |
| 5 years | 0.5 | | 24.04 |
| 10 years | 0.5 | | 1,187.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 31/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 28/02/2023 |
Alexander Link
BRD | Director/Board Member | 55 | 31/05/2020 |
Jochen Hummel
BRD | Director/Board Member | 56 | 04/02/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/12/22 | Buy | Chief Financial Officer | 2,000 | 0.0122% | ||
| 07/09/21 | Sell | Director | 7,790 | 0.0637% | ||
| 01/02/21 | Buy | Chairman | 6,355 | 0.1079% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.60% | -4.21% | +1.11% | -65.00% | 859K | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -2.85% | -3.17% | +22.37% | +75.25% | 59.26B | |
| +1.03% | -0.74% | +4.17% | +34.36% | 47.14B | |
| -0.50% | -4.29% | +26.64% | +33.47% | 42.91B | |
| -0.08% | +0.87% | +352.41% | +690.03% | 44.13B | |
| -1.70% | -1.56% | +2.91% | +99.00% | 40.79B | |
| +3.32% | +3.49% | +10.10% | +51.23% | 30.77B | |
| -2.68% | +2.92% | +29.63% | +22.72% | 29.31B | |
| +0.05% | -7.65% | -28.78% | +328.93% | 23.71B | |
| Average | +0.54% | -0.80% | +46.99% | +136.42% | 39.24B | |
| Weighted average by Cap. | +0.33% | -0.32% | +57.35% | +150.48% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.02K 22.44K 20.45K 38.51K 2.6M 39.03K 272K 105K 1.32M 101K 99.25K 4.26M |
| Net income | -3.35M -3.77M -3.13M -2.86M -5.38M -363M -5.45M -37.92M -14.68M -185M -14.17M -13.86M -594M | -314K -354K -294K -268K -504K -34.04M -511K -3.55M -1.38M -17.33M -1.33M -1.3M -55.68M |
| Net Debt | 10.46M 11.77M 9.78M 8.91M 16.77M 1.13B 17M 118M 45.79M 577M 44.19M 43.24M 1.85B | 10.97M 12.35M 10.26M 9.35M 17.6M 1.19B 17.84M 124M 48.03M 605M 46.36M 45.35M 1.94B |
Employees
2
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | €0.9100 | +4.60% | 0 |
| 01/10/26 | €0.8700 | -8.42% | 0 |
| 30/09/26 | €0.9500 | -0.52% | 0 |
| 29/09/26 | €0.9550 | +0.53% | 12 |
| 28/09/26 | €0.9500 | 0.00% | 0 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ECX Stock
Select your edition
All financial news and data tailored to specific country editions
